Mangalam Drugs And Organics Ltd.

₹33.09

1.2 (3.9%)

MANGALAM Share Price

Pharmaceuticals & Biotechnology

As on October 7, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 52.26 Cr

P/E Ratio-1.18

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	30.81	Bullish
10-DMA	31.21	Bullish
20-DMA	32.06	Bullish
50-DMA	30.01	Bullish
100-DMA	29.28	Bullish
200-DMA	30.71	Bullish

Historical Performance

1 Year

-53.2%

3 Years

-67.5%

5 Years

-77.1%

10 Years

-80.2%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024
Net Sales	2,321	3,176	3,686
Total Expenditure	2,470	2,824	3,512
Other Income	8	12	1
Operating Profit	-141	363	175
Interest	162	149	139
Depreciation	182	166	147
Profit Before Tax	-486	48	-111
Consolidated Net Profit	-444	67	-91
Adjusted EPS	-28	4	-6

Compounded Sales Growth

10 Years:-8.8

5 Years:-8.8

3 Years:-8.8

TTM:-6.1

Compounded Profit Growth

10 Years:37.4

5 Years:37.4

3 Years:37.4

TTM:18

Stock Price CAGR

10 Years:-15

5 Years:-25.8

3 Years:-31.2

TTM:-51.9

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:-5.7

last year:-28.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024
Share Capital	158	158	158
Total Reserves	872	1,332	1,200
Long-Term Borrowings	---	---	---
Total Non-Current Liabilities	153	258	338
Other Current Liabilities	247	204	223
Short Term Borrowings	946	710	746
Total Liabilities	3,150	3,664	3,337
Capital Work in Progress	---	14	---
Long Term Loans & Advances	3	20	23
Currents Investments	---	---	---
Short Term Loans and Advances	111	169	215
Total Current Assets	1,557	1,990	1,760
Total Assets	3,150	3,664	3,337
Adjusted Book Value	61	90	86

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -1.18, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -30.7%, indicating poor shareholder returns.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-141 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹2321 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 481309.1

No. of Shares: 14545 (Approx)

Performance:-51.9%

-518690.9

NIFTY Performance: -9.8%

1 day Top Gainers